Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Hypofractionated Radiotherapy followed by Surgery for the Treatment of Soft Tissue Sarcomas

Sarcoma

This phase II trial studies the effect of hypofractionated radiotherapy followed by surgery in treating patients with soft tissue sarcoma. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects. Giving hypofractionated radiotherapy followed by surgery may allow patients with sarcomas to be treated in a much more rapid and convenient fashion.

Disease Sites: Sarcoma

Phase: II

Investigator: Shinohara, Eric

NCTID: NCT04506008

Protocol No: VICCSAR2062

Blood-based, Point-of-need Assessment of CAR-T Vector Load in DLBCL Patients Undergoing Axicabtagene Ciloleucel (axi-cel) Therapy: A Multi-Site Study

Lymphoma

Disease Sites: Lymphoma

Phase: N/A

Investigator: Oluwole, Olalekan

NCTID:

Protocol No: VICC-IDCTT23426

Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Patients with Multiple Myeloma

Multiple Myeloma

Disease Sites: Multiple Myeloma

Phase: N/A

Investigator: Oluwole, Olalekan

NCTID: NCT05346835

Protocol No: VICC-XDCTT24033

Pattern of Changes in Immune Profile in the Setting of Chimeric Antigen Receptor T-Cell Therapy

Miscellaneous

Disease Sites: Miscellaneous

Phase: N/A

Investigator: Oluwole, Olalekan

NCTID:

Protocol No: VICCCTT2074

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form